Steve Orndorff PhD
Dr. Orndorff is a serial entrepreneur with more than 30 years experience in the biotechnology industry. Previously he was CEO of MicroBiome Therapeutics, a clinical stage company developing gut microbiome modulators for Type 2 diabetes and earlier he was founder and CEO of Ariel Pharmaceuticals, a specialty pharmaceutical company focused on clinical development of GPCR-EP4 receptor antagonists for migraine and chronic pain. He was also founder and CEO of Accera and Univera Pharmaceuticals. He is past Chairman of the Colorado Institute for Drug, Device & Diagnostic Development and is a founder and past Chairman of the Colorado BioScience Association, as well as a past President of the Society for Industrial Microbiology. Dr. Orndorff received a B.S. degree in biology from Virginia Polytechnic Institute and a Ph.D. in microbiology from the University of Maryland.